177 related articles for article (PubMed ID: 34020673)
1. The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection.
Zeman M; Czarnecki M; Chmielik E; Idasiak A; Skałba W; Strączyński M; Paul PJ; Czarniecka A
World J Surg Oncol; 2021 May; 19(1):154. PubMed ID: 34020673
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection.
Zeman M; Skałba W; Szymański P; Hadasik G; Żaworonkow D; Walczak DA; Czarniecka A
BMC Gastroenterol; 2022 Mar; 22(1):141. PubMed ID: 35346064
[TBL] [Abstract][Full Text] [Related]
3. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
4. The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: extended follow-up of a randomised controlled trial.
Bao QR; Pellino G; Spolverato G; Restivo A; Deidda S; Capelli G; Ruffolo C; Bianco F; Cuicchi D; Jovine E; Lombardi R; Belluco C; Amato A; La Torre F; Asteria C; Infantino A; Contardo T; Del Bianco P; Delrio P; Pucciarelli S
Int J Colorectal Dis; 2022 Jul; 37(7):1689-1698. PubMed ID: 35773492
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
[No Abstract] [Full Text] [Related]
6. Long-term oncologic outcomes following anastomotic leak after anterior resection for rectal cancer: does the leak severity matter?
Allaix ME; Rebecchi F; Famiglietti F; Arolfo S; Arezzo A; Morino M
Surg Endosc; 2020 Sep; 34(9):4166-4176. PubMed ID: 31617094
[TBL] [Abstract][Full Text] [Related]
7. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
10. Impact of anastomotic leakage on long-term oncologic outcome and its related factors in rectal cancer.
Noh GT; Ann YS; Cheong C; Han J; Cho MS; Hur H; Min BS; Lee KY; Kim NK
Medicine (Baltimore); 2016 Jul; 95(30):e4367. PubMed ID: 27472726
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
13. [Impact of anastomotic leakage on long-term survival in mid-to-low rectal cancer].
Jäger T; Nawara C; Neureiter D; Holzinger J; Öfner-Velano D; Dinnewitzer A
Chirurg; 2015 Nov; 86(11):1072-82. PubMed ID: 26428227
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
15. [Effect of preservation of left colic artery on postoperative anastomotic leakage of patients with rectal cancer after neoadjuvant therapy].
Teng WH; Wei C; Liu WJ; Liu S; Chen S; Zang WD
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):566-572. PubMed ID: 31238636
[No Abstract] [Full Text] [Related]
16. Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome.
Gagliardi G; Newton TR; Bailey HR
Colorectal Dis; 2013 Nov; 15(11):e659-64. PubMed ID: 24033889
[TBL] [Abstract][Full Text] [Related]
17. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
18. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
19. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
20. Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network" (SICO-CCN) multicentre collaborative study.
Degiuli M; Arolfo S; Evangelista A; Lorenzon L; Reddavid R; Staudacher C; De Nardi P; Rosati R; Elmore U; Coco C; Rizzo G; Belluco C; Forlin M; Milone M; De Palma GD; Rega D; Delrio P; Guerrieri M; Ortenzi M; Muratore A; Marsanic P; Restivo A; Deidda S; Zuin M; Pucciarelli S; De Luca R; Persiani R; Biondi A; Roviello F; Marrelli D; Sgroi G; Turati L; Morino M
Eur J Surg Oncol; 2018 Aug; 44(8):1233-1240. PubMed ID: 29705284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
